skip to content

Institute of Continuing Education (ICE)


The deadline for booking a place on this course has passed. Please use the 'Ask a Question' button to register your interest in future or similar courses.

Pharmacogenomics is playing a key role in our health care system. Pharmacogenomics and stratified health care ensure that healthcare professionals tailor the 'right treatment, for the right person, at the right time’ and is a fast developing area. This module provides a comprehensive overview of the analytical strategies and techniques used in pharmacogenomics and explore some of the challenges and limitations in this field (availability of patient material for studies of adverse drug reactions which tend to be rare, allelic heterogeneity between different ethnic groups, patient compliance etc.). Biomarkers are the predictive tools for optimising drug response and preventing adverse drug reactions thus this module will also provide an overview of the different type of genomic biomarkers currently in use or emerging. This module describes the complexity of pharmacogenomics and the effect of medication on individuals based on their genetic make-up i.e. tailoring drug treatment to improve patient response and techniques to stratify patients at risk of adverse drug reactions. The module uses examples of known validated pharmacogenomic tests relevant to the use of drug treatments and also use the expertise provided by the major clinical- and academic- industrial research cluster in biomedical science that is developing locally. The module provides a focus to develop interactions with industrial partners and academic groups developing research programs in stratified medicine across a broad range of diseases.

Please note: This course page is for those wishing to study for CPPD only. If you would like to study this module for credit, please click here.

Find out more about which modules you can apply for here


Fees and funding

The fee for 2020-21 will be £1,000 for Home students and for £2,250 for overseas students.

HEE funding is available for NHS staff wishing to apply to study Genomic Medicine at The University of Cambridge for study of individual modules or modules as part of a Postgraduate Certificate, Postgraduate Diploma or part-time Masters in Genomic Medicine.  Limited funding is also available for those wishing to extend their study from a Postgraduate Certificate or 4 modules to a Postgraduate Diploma or MSt. All funding is subject to availability.

Prospective students wishing to apply for HEE funding should apply for their course place in the first instance. If you are eligible for Health Education England [HEE] funding then your application for funding is made via the University and not directly to HEE.  If you receive a conditional offer of a place, we (the University) will confirm the amount of HEE funding we can offer. With your permission we will then share your details with HEE so that they can progress and approve your funding allocation. There is a useful funding application procedure flowchart on the HEE website here, click the ‘funding rules’ tab under each module description.

HEE funding is limited and only available for modules before the end of March 2021. You should make your application to us as swiftly possible in order to secure a place on the module(s) of your choice and secure any available funding.

Course dates

15 Feb 2021 to 19 Feb 2021

Course duration

1 week

Apply by

05 Feb 2021

Course fee

Home: £1,000
Overseas: £2,250

Course director

Programme director

Academic Directors, Course Directors and Tutors are subject to change, when necessary.


Virtual Classroom
(via Zoom or equivalent)

Qualifications / Credits

15 credits at Master of Studies

Course code